A lot of people trying to lose weight and different in many ways, but what is the story of this new method?
A new study found that the use of medication for the treatment of diabetes Araglutayd - liraglutide helps obese people in the disposal rate of 8 kg per year, having been approved for use of this drug in the United States last year for the purpose of weight loss.
Researchers organizers said the study, published in the scientific journal New England Journal of Medicine that all patients were able to lose weight during the 56 weeks through the use of this medicine.
The researchers targeted a 3731 joint over the age of 18, and they have a body mass index equal to 30 or more, while a healthy body mass index between 19-25.
Participants were divided into two groups:
The first group contains two-thirds of the participants, were given medication to Araglutayd exercise with aerobics.
The second group did not conduct any change in lifestyle and did not eat the medicine.
The participants in the first set to take a larger dose of the drug from patients with diabetes about 3 mg, were injected under the skin every day.
The researchers found the following results:
Subscribers lost the first set in approximately 3 kg, while the loss of the first set of weight tripled.
It lost about 63% of those taking medicine for Araglutayd 5% of their weight at least.
The side effects of using the drug for weight loss:
Digestive problems
Gallstones.
A slight increase in risk of breast cancer.
The researchers pointed to the need for further future research to make sure the subject of the high risk of breast cancer as a result of taking the drug
A new study found that the use of medication for the treatment of diabetes Araglutayd - liraglutide helps obese people in the disposal rate of 8 kg per year, having been approved for use of this drug in the United States last year for the purpose of weight loss.
Researchers organizers said the study, published in the scientific journal New England Journal of Medicine that all patients were able to lose weight during the 56 weeks through the use of this medicine.
The researchers targeted a 3731 joint over the age of 18, and they have a body mass index equal to 30 or more, while a healthy body mass index between 19-25.
Participants were divided into two groups:
The first group contains two-thirds of the participants, were given medication to Araglutayd exercise with aerobics.
The second group did not conduct any change in lifestyle and did not eat the medicine.
The participants in the first set to take a larger dose of the drug from patients with diabetes about 3 mg, were injected under the skin every day.
The researchers found the following results:
Subscribers lost the first set in approximately 3 kg, while the loss of the first set of weight tripled.
It lost about 63% of those taking medicine for Araglutayd 5% of their weight at least.
The side effects of using the drug for weight loss:
Digestive problems
Gallstones.
A slight increase in risk of breast cancer.
The researchers pointed to the need for further future research to make sure the subject of the high risk of breast cancer as a result of taking the drug
